WUHAN ZHONG YUAN RUI DE BIOLOGICAL PRODUCTS
Wuhan Zhong Yuan Rui De Biological Products manufactures bio-pharmaceutical products.
WUHAN ZHONG YUAN RUI DE BIOLOGICAL PRODUCTS
Industry:
Biopharma Manufacturing
Founded:
2010-01-01
Address:
Wuhan, Hubei, China
Country:
China
Status:
Active
Similar Organizations
Advanced Nano Products
Advanced Nano Products manufactures nano-sized material products.
Zim Laboratories
Zim Laboratories is a manufacturer of pharmaceutical products.
More informations about "Wuhan Zhong Yuan Rui De Biological Products"
SALE OF RUIDE OPERATIONS - CSL Limited
Aug 30, 2024 with Chengdu Rongsheng Pharmaceutical Co., Ltd. (Chengdu Rongsheng) to sell its Wuhan Zhong Yuan Rui De Biologicals Products (Ruide) plasma collection and …See details»
Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd.
Nov 1, 2024 Explore Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 1 literature, Drug:Factor …See details»
Acquisition of a Chinese plasma fractionator - CSL
Fractionator - Wuhan Zhong Yuan Rui De Biological Products, for US$352 million(1) (1) The agreement includes a milestone based performance mechanism to enable CSL to increase its …See details»
CSL to purchase 80% stake in Chinese firm Ruide for $352m
Global biotechnology company CSL has agreed to buy 80% stake in Chinese plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biological Products (Ruide) from …See details»
CSL Completes Transaction to Acquire a Majority Stake in Chinese …
Wuhan Zhong Yuan Rui De Biological Products Co. Ltd. (Ruide). As previously announced to the Australian Securities Exchange on 13 June 2017, CSL has acquired 80 per cent equity in the …See details»
CSL to acquire majority stake in Chinese plasma fractionator …
Jun 13, 2017 acquire 80 per cent equity of plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biological Products Co. Ltd. (“Ruide”) from Humanwell Healthcare Group …See details»
Wuhan Zhong Yuan Rui De Biological Products Co., Ltd.
Find company research, competitor information, contact details & financial data for Wuhan Zhong Yuan Rui De Biological Products Co., Ltd. of Wuhan, Hubei. Get the latest business insights …See details»
CSL to acquire majority stake in Chinese plasma …
Jun 12, 2017 CSL to acquire majority stake in Chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products - CSL to acquire an 80 per cent stake in plasma-derived therapies manufacturer Wuhan Zhong ...See details»
CSL acquires major stake in Ruide China - biospectrumasia.com
Aug 19, 2024 CSL Limited has agreed to acquire 80 per cent equity of plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biological Products Co. Ltd. (“Ruide”) from …See details»
CSL to acquire Chinese blood plasma fractionator
Jun 13, 2017 CSL will acquire the stake in Wuhan Zhong Yuan Rui De Biological Products (Ruide) from Humanwell Healthcare Group, a Shanghai-listed pharmaceutical company, CSL said in a statement on Tuesday. The deal is …See details»
CSL to acquire majority stake in Chinese plasma fractionator …
MELBOURNE, Australia, June 12, 2017 /PRNewswire/ --CSL Limited (ASX:CSL; USOTC:CSLLY) announced today that it has agreed to acquire 80 per cent equity of plasma-derived therapies …See details»
CSL Completes Transaction to Acquire a Majority Stake in Chinese …
CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that it has closed a joint venture transaction with Humanwell Healthcare Group Co. Ltd. (Humanwell; Shanghai exchange: …See details»
CSL to Acquire Majority Stake in Chinese Plasma Fractionator …
Jun 13, 2017 CSL Limited has agreed to acquire 80 per cent equity of plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biological Products Co. Ltd. from Humanwell …See details»
Wuhan Zhong Yuan Rui De Biological Products acquired by CSL
CSL acquires Wuhan Zhong Yuan Rui De Biological Products on 2017-06-12 for $352000000. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ...See details»
Wuhan Zhong Yuan Rui De Biological Products - PitchBook
Wuhan Zhong Yuan Rui De Biological Products General Information Description. Manufacturer of plasma-derived products based in Wuhan, China. The company's plasma-derived products …See details»
CSL Limited ready for China - Matthew Haupt | Livewire
Jun 16, 2017 On Tuesday, CSL Limited (ASX: CSL) announced its decision to acquire 80% of the equity of plasma-derived therapies manufacturer, Wuhan Zhong Yuan Rui De Biological …See details»
CSL takes on China - Intelligent Investor
Jun 28, 2017 With this as a backdrop, CSL's push into the Chinese market makes perfect sense. The company has purchased an 80% stake in plasma therapy maker Wuhan Zhong Yuan Rui …See details»
CSL Sells Wuhan Plasma Collection, Fractionation Ops
Sep 6, 2024 CSL Limited (ASX:CSL) has announced the sale of its Wuhan Zhong Yuan Rui De Biologicals Products (Ruide) plasma collection and fractionation operations to Chengdu …See details»
CSL : to acquire majority stake in Chinese plasma fractionator …
Jun 16, 2017 CSL Limited (ASX:CSL; USOTC:CSLLY) announced today that it has agreed to acquire 80 per cent equity of plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui …See details»
Optical sectioning methods in three-dimensional bioimaging
3 days ago In recent advancements in life sciences, optical microscopy has played a crucial role in acquiring high-quality three-dimensional structural and functional information. However, the …See details»